NyheterForskning

Aktuella utlysningar, vecka 48, 2017

Publicerat 2017-11-27 16:07. Uppdaterat 2017-12-05 11:37

KI Grants Office tipsar om aktuella utlysningar

Swedish and Nordic grants

Research grants – KI SFO Stem cells and Regenerative medicine

The SFO will during the period 2018-2020 support up to four research grants for projects within the field of stem cells and regenerative medicine, one to two open to all candidates and two to three for candidates up to 12 years after obtaining their PhD.  Applicants should be affiliated 100% at KI and/or the Stockholm County Council (SLL) at the time of starting the project. Priority will be given to high quality innovative projects. Eligible projects will be supported with up to 2M SEK/year for 3 years. Grants can be used to cover salaries, running costs, equipment and administrative costs.

Closing date: 15 Jan 2018

Research grants – KI SFO Stem cells and Regenerative medicine 

Clinical Research grants – KI SFO Stem cells and Regenerative medicine

The SFO will during the period 2018-2020 support clinical-translational research within the area of stem cells, regenerative medicine, and cellular therapies with up to 12 MSEK. Two research grants, each at 1 MSEK/year over 3 years will be announced 2018, and another two will be announced 2019. These grants aim at supporting clinically active physicians, who have both a MD and a PhD degree and are affiliated 100% to SLL and KI at the time of starting the project. During 2018, at least one of these grants will be awarded to a candidate who is within 12 years after obtaining PhD degree, while one is open to all candidates. During the period of research support, the applicant should perform clinical work 20-50% of full time. Priority will be given to high quality clinical projects, or translational projects with a clear clinical potential. Eligible projects will be supported with up to 1MSEK/year for 3 years. Grants can be used to cover salaries, running costs, equipment and administrative costs.

Closing date: 15 Jan 2018

Clinical Research grants – KI SFO Stem cells and Regenerative medicine 

Anslag –  Anders Karitz Stiftelse

Anders Karitz Stiftelse har bl.a. till ändamål att främja filosofisk forskning och betydelsefullt populärvetenskapligt författarskap och meddelar att sammanlagt ca 250 000 kr kan utdelas i form av flera bidrag.

Closing date: 19 Jan 2018

Anslag –  Anders Karitz Stiftels (PDF)

Irisstipendiet - Iris Jonzén-Sandbloms and Greta Jonzén

Detta syftar till att stödja utbildning av framåtsträvande kvinnor med ett speciellt intresse av att stödja kvinnor som verkar eller kommer att verka inom områden som är av betydelse för andra kvinnor. 

Closing date: 15 Jan 2018

Irisstipendiet - Iris Jonzén-Sandbloms and Greta Jonzén 

Scholarships – The Foundation Blanceflor

The Foundation Blanceflor awards each year scholarships to people with Italian or Swedish citizenship for advanced studies/research, preferably post-doctoral, in medical, natural and technical sciences.

Closing date: 1 Feb 2018

Scholarships – The Foundation Blanceflor 

Postdoctoral fellowships in Japan – Swedish Foundation for Strategic Research (SSF)  

These aim to stimulate young Swedish researchers to conduct co-operative research activities with leading Japanese research groups. The programme covers a one to two-year stay in Japan for two candidates. 

Closing date: 28 Feb 2018

Postdoctoral fellowships in Japan – Swedish Foundation for Strategic Research (SSF)  

SSF Works; Instrument, Technique, and Method Development Projects 2017

Technique development is a necessary factor for competitive research and industrialization. Yet, direct public funding with this aim is largely lacking. The Swedish Foundation for Strategic Research (SSF) therefore invests SEK 240 million in the national announcement “SSF Works: Instrument, Technique, and Method Development Projects 2017″.

Closing date: 21 March 2018

SSF Works; Instrument, Technique, and Method Development Projects 2017 

European grants

Partner your antibodies - Bayer

Bayer invites applications for its partner your antibodies call. This supports the evaluation of an antibody or derivative and the promotion of its exploration for a potential new drug development. The project may be in the fields of oncology, cardiology, kidney diseases, haemophilia as well as gynaecology and address a specific target or pathway. The central focus is bioactivity. Financial support for research expenses and collaborative drug discovery opportunities are available.

 Closing date: 31 Dec 2017

Partner your antibodies - Bayer 

Congenital adrenal hyperplasia grant - European Society for Paediatric Endocrinology

The European Society for Paediatric Endocrinology, on behalf of the International Fund raising for Congenital Adrenal Hyperplasia, invites letters of intent for their congenital adrenal hyperplasia grant. This supports research on congenital adrenal hyperplasia and aims to improve understanding of pathophysiology of the disease and its management. Grants are worth up to €150,000 each over three years.

Closing date: 15 Jan 2018

Congenital adrenal hyperplasia grant - European Society for Paediatric Endocrinology 

G.B. Morgagni Awards - Servier

Applications/nominations are invited for the two G.B. Morgagni Awards in the field of diabetes and its complications. Candidates for the Career Achievement Gold Medal Award should be nominated by at least two individuals. Young European scientists (not yet 40 on January 1, 2018) are invited to apply for the Silver medal Young Investigator Award.

Closing date: 1 Feb 2018

G.B. Morgagni Awards - Servier

Gold medal - European Molecular Biology Organisation

The EMBO Gold Medal is awarded annually to young scientists for outstanding contributions to the life sciences in Europe. Molecular biologists currently working in one of the EMBC member states who are under the age of 40, or within 10 years of having obtained their PhD or equivalent, may be nominated by EMBO members.

Closing date: 1 Feb 2018

Gold medal - European Molecular Biology Organisation

US grants

Federal Funding agencies

NIH Blue Print: Development and Validation of Technologies for Rapid Isolation and Characterization of Extracellular Vesicles of Central Nervous System Origin (R21): NIH

This Funding Opportunity Announcement (FOA) encourages applications that will develop novel technologies and/or tools for the isolation and characterization of extracellular vesicles (EVs) of Central Nervous System (CNS) origin. The primary focus of the technology development includes robust and reproducible CNS-EV isolation methods. Specifically, there is a need to establish technologies for the isolation and purification of CNS-EVs from peripheral samples and the characterization of CNS-EV types, cargos, and origin, as well as to validate these methods for further analyses. Validation of these technologies may include the analysis of the full range of EV composition such as RNA, proteins, lipids, and metabolites.

Closing dates: applications due by 5pm local time of applicant organisation on January 22, 2018.

NIH Blue Print: Development and Validation of Technologies for Rapid Isolation and Characterization of Extracellular Vesicles of Central Nervous System Origin (R21): (FOA): RFA-MH-18-600 (R01)

Mechanisms, Models, Measurement, & Management in Pain Research (R01, R21) - NIH

The purpose of this Funding Opportunity Announcement (FOA) is to inform the scientific community of the pain research interests of the various Institutes and Centers (ICs) at the National Institutes of Health (NIH) and to stimulate and foster a wide range of basic, clinical, and translational studies on pain as they relate to the missions of these ICs.  New advances are needed in every area of pain research, from the micro perspective of molecular sciences to the macro perspective of behavioral and social sciences.  Although great strides have been made in some areas, such as the identification of neural pathways of pain, the experience of pain and the challenge of treatment have remained uniquely individual and unsolved. Furthermore, our understanding of how and why individuals transition to a chronic pain state after an acute injury is limited. Research to address these issues conducted by interdisciplinary and multidisciplinary research teams is strongly encouraged, as is research from underrepresented, minority, disabled, or women investigators.

Closing dates: standard dates apply until 8 May 2019.

Mechanisms, Models, Measurement, & Management in Pain Research (R01, R21) - NIH, (FOA):  PA-18-141 (R01); PA-18-159 (R21)

Länkar